Mohammed Sahloul MD in Palos Heights, Illinois

Home Illinois Palos Heights

Mohammed Sahloul MD has Sleep Medicine as his primary medical specialty. Their primary office is: 12820 S Ridgeland Ave in Palos Heights, Illinois.

They're a part of the: Midwest Pulmonary Critical Care And Sleep Consultants Llc medical group which has around 34 members. You can call their office at 708-371-8006 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1988 (around 36 years of experience). They are listed as doing telehealth appointments.

Mohammed Z Sahloul MD Office Phone and Directions

Mohammed Sahloul MD
Midwest Pulmonary Critical Care And Sleep Consultants Llc
12820 S Ridgeland Ave
Palos Heights, Illinois 60463
708-371-8006

Patient Ratings
Please rate your experience with Mohammed Sahloul MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 708-371-8006

Enter a starting address:

Healthcare Info for Mohammed Sahloul MD

Additional Medical Specialties Include:
CRITICAL CARE (INTENSIVISTS), INTERNAL MEDICINE, PULMONARY DISEASE

Medical School: Sorry, his university is not listed
Graduation Year: 1988
The Primary Medical Specialty for Mohammed Sahloul MD is listed as: Sleep Medicine
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 36
PAC (PECOS ID)#: 2264334697
NPI #: 1447214002
NPI Created On: 04/12/2006
NPI Last Updated Listed as: 06/08/2018
Primary Taxonomy Code: 207RP1001X
License Number:
036085019
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Arabic, Spanish.

Services and Procedures include:

Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
Test for exercise-induced lung stress
Initiation and management of continued pressured respiratory assistance by mask or breathing tube
Determination of lung volumes using plethysmography
Determination of lung volumes using plethysmography
Measurement of lung diffusing capacity
Measurement of lung diffusing capacity
Sleep monitoring of patient (6 years or older) in sleep lab
Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube
New patient office or other outpatient visit, typically 30 minutes
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 15 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788241765

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology

Name of Drug #1: OPSUMIT

Open Associated Drug #1: 66215-501-30

Drug or Biological: Drug

Product Category #2: Cardiology

Name Of Drug #2:: UPTRAVI

Associated Drug #2: 66215-602-14

Payments Total: $2

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801706291

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $6

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802025543

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802067101

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802136009

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: ANORO ELLIPTA

Open Associated Drug #1: 0173-0869-06

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802328105

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802348905

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $9

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802364947

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802448309

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $3

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802902323

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Providers in Midwest Pulmonary Critical Care And Sleep Consultants Llc

1.Nadia Abdessalam

12820 S Ridgeland Ave
Palos Heights Il 60463-2389
Midwest Pulmonary Critical Care And Sleep Consultants Llc
Nurse Practitioner

2.Fadi Aldaas

12820 S Ridgeland Ave
Palos Heights Il 60463-2389
Midwest Pulmonary Critical Care And Sleep Consultants Llc
Critical Care (intensivists)

3.Dinas Aleksonis

11900 Southwest Hwy
Palos Park Il 60464-1200
Midwest Pulmonary Critical Care And Sleep Consultants Llc
Internal Medicine

4.Mousab Almusaddy Md

12820 S Ridgeland Ave
Palos Heights Il 60463-2389
Midwest Pulmonary Critical Care And Sleep Consultants Llc
Pulmonary Disease

5.Juanbosco Ayala

12820 S Ridgeland Ave
Palos Heights Il 60463-2389
Midwest Pulmonary Critical Care And Sleep Consultants Llc
Pulmonary Disease

6.Jennifer Cavett

12820 S Ridgeland Ave
Palos Heights Il 60463-2389
Midwest Pulmonary Critical Care And Sleep Consultants Llc
Nurse Practitioner

View all 34 members of Midwest Pulmonary Critical Care And Sleep Consultants Llc medical group